Method for preparing pyrrolidine oximes

Details for Australian Patent Application No. 2005217153 (hide)

Owner Applied Research Systems ARS Holding N.V.

Inventors Nadler, William; Pupowicz, Doris

Agent Griffith Hack

Pub. Number AU-A-2005217153

PCT Pub. Number WO2005/082848

Priority 04100773.3 26.02.04 EP

Filing date 28 February 2005

Wipo publication date 9 September 2005

International Classifications

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082848 Priority application(s): WO2005/082848

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

23 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005217154-Use of a serum-free cell culture medium for the production of IL-18BP in mammalian cells

2005217148-A method of providing a purified, virus safe antibody preparation